Huber Capital Management’s GSK GSK Stock Holding History

Huber Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$650K	Buy	12,398 +69	+0.6%	+$3.65K	0.1%	76
2026 Q1	$680K	Sell	12,329 -80	-0.6%	-$4.33K	0.11%	74
2025 Q4	$609K	Hold	12,409	–	–	0.09%	90
2025 Q3	$536K	Hold	12,409	–	–	0.08%	94
2025 Q2	$477K	Buy	12,409 +5,480	+79%	+$209K	0.08%	95
2025 Q1	$268K	Hold	6,929	–	–	0.05%	103
2024 Q4	$234K	Buy	6,929 +2,001	+41%	+$72K	0.05%	104
2024 Q3	$201K	Buy	+4,928	New	+$202K	0.04%	99
2024 Q2	–	Sell	-25,692	Closed	-$1.1M	–	97
2024 Q1	$1.1M	Sell	25,692 -29	-0.1%	-$1.2K	0.25%	71
2023 Q4	$953K	Sell	25,721 -29,671	-54%	-$1.07M	0.24%	76
2023 Q3	$2.01M	Sell	55,392 -20,311	-27%	-$721K	0.47%	53
2023 Q2	$2.7M	Hold	75,703	–	–	0.65%	45
2023 Q1	$2.69M	Buy	75,703 +27,031	+56%	+$946K	0.67%	46
2022 Q4	$1.71M	Buy	48,672 +23,599	+94%	+$786K	0.43%	52
2022 Q3	$738K	Buy	25,073 +39	+0.2%	+$1.48K	0.21%	65
2022 Q2	$1.36M	Sell	25,034 -3,600	-13%	-$199K	0.38%	52
2022 Q1	$1.56M	Sell	28,634 -1,600	-5%	-$86.9K	0.39%	56
2021 Q4	$1.67M	Sell	30,234 -2,966	-9%	-$154K	0.44%	50
2021 Q3	$1.59M	Sell	33,200 -800	-2%	-$40.2K	0.41%	53
2021 Q2	$1.69M	Sell	34,000 -800	-2%	-$38.4K	0.43%	56
2021 Q1	$1.55M	Sell	34,800 -2,880	-8%	-$131K	0.42%	53
2020 Q4	$1.73M	Buy	37,680 +2,880	+8%	+$132K	0.57%	49
2020 Q3	$1.64M	Sell	34,800 -106,080	-75%	-$5.31M	0.6%	44
2020 Q2	$7.18M	Sell	140,880 -10,400	-7%	-$534K	1.47%	24
2020 Q1	$7.17M	Hold	151,280	–	–	1.31%	26
2019 Q4	$8.89M	Sell	151,280 -29,840	-16%	-$1.66M	1.17%	29
2019 Q3	$9.66M	Sell	181,120 -19,200	-10%	-$988K	1.2%	29
2019 Q2	$10M	Sell	200,320 -40,080	-17%	-$2.01M	1.19%	31
2019 Q1	$12.6M	Buy	+240,400	New	+$12M	1.33%	30

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Huber Capital Management's GSK Position: Q2 2026 in Review

Huber Capital Management increased its GSK (GSK) stake by 0.56% in Q2 2026, buying an estimated $3.65K and bringing the position to 12,398 shares worth $650K. The position accounts for 0.1% of the portfolio, ranked #76.

Huber Capital Management first reported a position in GSK in Q1 2019 and has held it in 29 quarters since. The position peaked at $12.6M in Q1 2019. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Huber Capital Management held 12,398 shares of GSK worth $650K as of Q2 2026.
Huber Capital Management bought 69 GSK shares in Q2 2026, an estimated $3.65K.
GSK made up 0.1% of Huber Capital Management's portfolio in Q2 2026, its #76 holding.
Huber Capital Management first reported a position in GSK in Q1 2019 and has held it in 29 quarters since.
Huber Capital Management's GSK position peaked at $12.6M in Q1 2019.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Huber Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.